| 期 |
标题 |
文件 |
| 卷 19, 编号 1 (2025) |
Mechanisms of neuromuscular junction dysfunction in amyotrophic lateral sclerosis |
(Rus)
(Eng)
|
|
Khabibrakhmanov A., Akhmadieva L., Nagiev K., Mukhamedyarov M.
|
| 卷 19, 编号 1 (2025) |
Potential biochemical markers of epilepsy |
(Rus)
(Eng)
|
|
Maksimova M., Abbasova E., Shitova A.
|
| 卷 19, 编号 1 (2025) |
Pharmacological functional MRI technology: potential for use in neurology |
(Rus)
(Eng)
|
|
Raskurazhev A., Tanashyan M., Morozova S., Kuznetsova P., Annushkin V., Mazur A., Panina A., Spryshkov N., Piradov M.
|
| 卷 18, 编号 4 (2024) |
A Genetic Perspective on Ischemic Stroke: Recent Advances and Future Directions |
(Rus)
(Eng)
|
|
Chandra Sekar P., Veerabathiran R.
|
| 卷 18, 编号 4 (2024) |
Primary Progressive Aphasia: Variants and Main Language Domains |
(Rus)
(Eng)
|
|
Akhmadullina D., Fedotova E.
|
| 卷 18, 编号 4 (2024) |
Aerobic Exercise in Rehabilitation of Patients with Parkinson’s Disease |
(Rus)
(Eng)
|
|
Guseva O.
|
| 卷 18, 编号 4 (2024) |
Sensitivity and Specificity of the Diagnostic Method for Detecting α-Synuclein as a Histological Marker for Parkinson's Disease in Salivary Gland Tissues: a Systematic Review and Meta-analysis |
(Rus)
(Eng)
|
|
Khacheva K., Illarioshkin S., Karabanov A.
|
| 卷 18, 编号 4 (2024) |
Cellular and Molecular Mechanisms Underlying Transcranial Magnetic Stimulation: Experimental Data for Evaluating Changes in Nervous Tissue |
(Rus)
(Eng)
|
|
Krasilnikova A., Egorova A., Voronkov D., Poydasheva A., Glinkina V., Sukhorukov V.
|
| 卷 18, 编号 3 (2024) |
Spectrum of Non-Motor Symptoms in Parkinson’s Disease — a Review |
(Rus)
(Eng)
|
|
Rizvi S., Palimar V., Gupta C., Andrade L.
|
| 卷 18, 编号 3 (2024) |
Magnetic Resonance Imaging Diagnostics of Vascular Myelopathies: from Basic Sequences to Promising Imaging Protocols |
(Rus)
(Eng)
|
|
Ponomarev G., Agafonov A., Barilyak N., Amelin A., Skoromets A.
|
| 卷 18, 编号 3 (2024) |
Deep Brain Stimulation Withdrawal Syndrome, a Rare Life-Threatening Condition in Neurology and Neurosurgery |
(Rus)
(Eng)
|
|
Bril E., Tomskiy A., Gamaleya A., Poddubskaya A., Kesarev D., Fedorova N.
|
| 卷 18, 编号 3 (2024) |
Oxytocin and Vasopressin in Emotional Memory and “Face Reading”: a Neurobiological Approach and Clinical Aspects |
(Rus)
(Eng)
|
|
Gorina Y., Lopatina O., Mararitsa L.
|
| 卷 18, 编号 2 (2024) |
Dysphagia in neurological disorders |
(Rus)
(Eng)
|
|
Zaytsevskaya S., Lyukmanov R., Berdnikovich E., Suponeva N.
|
| 卷 18, 编号 2 (2024) |
Rapid eye movement sleep behavior disorder: modern concept and Parkinson’s disease correlation |
(Rus)
(Eng)
|
|
Khasanova D., Zalyalova Z., Ilina G., Bagdanova N.
|
| 卷 18, 编号 2 (2024) |
Monoclonal antibodies as analgesia of chronic low back pain: a systematic review and meta-analysis of efficacy and safety |
(Rus)
(Eng)
|
|
Budiputra N., Budiputri C., Muljono M.
|
| 卷 18, 编号 2 (2024) |
Optimization of laboratory diagnostics of neuromyelitis optica spectrum disorders: indications and algorithms |
(Rus)
(Eng)
|
|
Simaniv T., Krasnov V., Lapin S., Bembeeva R., Korobko D., Belko E., Shabalina А.
|
| 卷 18, 编号 1 (2024) |
Surgical Treatment Options for Degenerative Lumbosacral Spinal Stenosis |
(Rus)
(Eng)
|
|
Yusupova A., Gushcha A., Arestov S., Petrosyan D., Kartavykh R., Simonyan A., Kiselev A.
|
| 卷 18, 编号 1 (2024) |
PreventS-MD®: a New Digital Technology to Maintain Cardiovascular Prevention in Routine Clinical Practice |
(Rus)
(Eng)
|
|
Kravchenko M., Gnedovskaya E., Feigin V., Piradov M.
|
| 卷 17, 编号 4 (2023) |
Poststroke Asthenic Disorder |
(Rus)
(Eng)
|
|
Kutlubaev M., Akhmetova A.
|
| 卷 17, 编号 4 (2023) |
Neurobehavioral Testing as Cognitive Function Evaluation tool in Experimentally Induced Neurodegeneration in Mice |
(Rus)
(Eng)
|
|
Panina Y., Lopatina O., Mosyagina A., Komleva Y., Morgun A., Gorina Y., Hilazheva E.
|
| 卷 17, 编号 3 (2023) |
Pathophysiology and biomechanics of stretch-induced peripheral nerve injuries |
(Rus)
|
|
Karakulova Y., Kloyan G., Muravev S., Shitoev I., Nikitin V., Ivanova M.
|
| 卷 17, 编号 2 (2023) |
COVID-19 Features in Patients with Multiple Sclerosis: Main Approaches to Their Management, Treatment, and Vaccination |
(Rus)
|
|
Malko V., Bisaga G., Topuzova M., Ternovykh I., Alekseeva T.
|
| 卷 17, 编号 2 (2023) |
Several Risk Factors for Aneurysmal Subarachnoid Hemorrhage |
(Rus)
|
|
Shnyakin P., Kazadaeva I.
|
| 卷 17, 编号 2 (2023) |
B Cell Depletion Therapy as a Cutting-Edge Treatment of Demyelinating Diseases of the Central Nervous System |
(Rus)
|
|
Simaniv T., Belkina A., Zakharova M.
|
| 卷 17, 编号 1 (2023) |
Molecular mechanisms of neuroprotective effects of thyroid hormones and their metabolites in acute brain ischemia |
(Rus)
|
|
Filimonov D., Yevtushenko S., Fedorova A.
|
| 卷 17, 编号 1 (2023) |
Neuroinflammation as secondary damage in head injury |
(Rus)
|
|
Karchevskaya A., Payushina O., Sharova E., Oknina L., Titov O.
|
| 卷 16, 编号 4 (2022) |
The structural patterns of the potentiation and the blockade of inhibitory cys-loop receptors through the transmembrane domain |
(Rus)
|
|
Rossokhin A.
|
| 卷 16, 编号 4 (2022) |
Multiple system atrophy: diagnostic methods and biomarkers |
(Rus)
|
|
Andreev M., Fedotova E.
|
| 卷 16, 编号 4 (2022) |
Insomnia and its management in patients with panic disorder |
(Rus)
|
|
Korabelnikova E., Yakovleva E.
|
| 卷 16, 编号 3 (2022) |
The cerebrovascular, neuroprotective and antiarrhythmic properties of the anxiolytic fabomotizole |
(Rus)
|
|
Mirzoyan R., Balasanyan M., Topchyan H., Hakobyan V., Gan'shina T., Khaylov N., Kurdyumov I., Turilova A., Antipova Т., Kraineva V., Seredenin S.
|
| 卷 16, 编号 3 (2022) |
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: approaches to risk management |
(Rus)
|
|
Polushin A., Zalyalov Y., Totolyan N., Kulagin A., Skoromets A.
|
| 卷 16, 编号 2 (2022) |
NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders |
(Rus)
|
|
Belozor O., Shuvaev A., Fritsler Y., Shuvaev A.
|
| 卷 16, 编号 2 (2022) |
Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic |
(Rus)
|
|
Petrov A., Votintseva M., Stolyarov I.
|
| 卷 16, 编号 2 (2022) |
Morphology and pathogenesis of white matter changes in chronic cerebrovascular disease |
(Rus)
|
|
Gulevskaya T., Anufriev P., Tanashyan М.
|
| 卷 16, 编号 1 (2022) |
Pineal gland: structural variants and their role in neurological and psychiatric disorders |
(Rus)
|
|
Shilova A., Ananyeva N., Safonova N., Lukina L.
|
| 卷 15, 编号 4 (2021) |
The quality of artificial intelligence algorithms for identifying manifestations of multiple sclerosis on magnetic resonance imaging (systematic review) |
(Rus)
|
|
Chernyaeva G., Morozov S., Vladzimirskyy A.
|
| 卷 15, 编号 4 (2021) |
Primary progressive aphasias: clinical and genetic heterogeneity and diagnostic difficulties |
(Rus)
|
|
Litvinenko I., Kolmakova К., Emelin А., Lobzin V.
|
| 卷 15, 编号 3 (2021) |
Cognitive motor dissociation in patients with chronic disorders of consciousness: a literature review |
(Rus)
|
|
Belkin V., Ilina K., Ryabinkina Y.
|
| 卷 15, 编号 3 (2021) |
Mechanisms of neurogenesis and angiogenesis in ischaemic stroke: literature review |
(Rus)
|
|
Koroleva E., Alifirova V.
|
| 卷 15, 编号 2 (2021) |
Certain aspects of brain tumor angiogenesis |
(Rus)
|
|
Frantsiyants E., Rostorguev E., Sheiko E.
|
| 卷 15, 编号 2 (2021) |
The pharmacogenomics of lamotrigine (a literature review) |
(Rus)
|
|
Azhigova A., Broutian A., Vlasov P.
|
| 卷 15, 编号 1 (2021) |
Comparing the results of surgical and conservative treatment of patients with supratentorial hypertensive intracerebral hemorrhage. A new look at previously known randomized studies |
(Rus)
|
|
Godkov I., Dashyan V.
|
| 卷 14, 编号 4 (2020) |
Rehabilitation of elderly patients at risk of falling: the value of psychophysiological parameters and cognitive-motor training using virtual reality |
(Rus)
|
|
Klochkov A., Khizhnikova A., Fuks A., Kotov-Smolenskiy A., Suponeva N., Piradov M.
|
| 卷 14, 编号 4 (2020) |
DNA methylation in Parkinson disease |
(Rus)
|
|
Yakovenko E., Fedotova E., Illarioshkin S.
|
| 卷 14, 编号 3 (2020) |
Non-pharmacological prevention and correction of cognitive disorders |
(Rus)
|
|
Raskurazhev A., Kuznetsova P., Tanashyan M.
|
| 卷 14, 编号 2 (2020) |
Legal Aspects of Medical Care in Hospital-acquired Ischaemic Stroke |
(Rus)
|
|
Voznyuk I., Kolomentsev S., Nikitin Y.
|
| 卷 14, 编号 2 (2020) |
Sleep and Wakefulness Disorders in Vascular Cognitive Impairment |
(Rus)
|
|
Merkulova T., Kovrov G., Yakhno N.
|
| 卷 14, 编号 2 (2020) |
Neurological aspects of COVID-19 |
(Rus)
|
|
Tanashyan M., Kuznetsova P., Raskurazhev A.
|
| 卷 14, 编号 1 (2020) |
The role of long noncoding RNAs in ischaemic stroke |
(Rus)
|
|
Novikova L., Gareev I., Raskurazhev A., Beylerli O., Minibaeva G.
|
| 卷 13, 编号 4 (2019) |
Functional neurosurgery in Parkinson’s disease in Russia |
(Rus)
|
|
Tomskiy А., Bril E., Gamaleya A., Fedorova N., Levin O.
|
| 卷 13, 编号 4 (2019) |
Clinical features and mechanisms of the development of cognitive impairment in children with obstructive sleep apnoea syndrome |
(Rus)
|
|
Kalashnikova T., Yastrebova A.
|
| 卷 13, 编号 4 (2019) |
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: risk reduction, management and possibilities for subsequent immunoregulation |
(Rus)
|
|
Khachanova N., Boyko A., Shumilina M., Smagina I., Malkova N., Sivertseva S., Popova E., Khaibullin T.
|
| 卷 13, 编号 4 (2019) |
Group I metabotropic glutamate receptors (mGluR1/5) and neurodegenerative diseases |
(Rus)
|
|
Solntseva E., Rogozin P., Skrebitsky V.
|
| 卷 13, 编号 4 (2019) |
Therapeutic drug monitoring of levetiracetam in newborns |
(Rus)
|
|
Bondareva I., Ivzhits M., Zyryanov S., Chenkurov M.
|
| 卷 13, 编号 2 (2019) |
Sacroiliac joint syndrome: aetiology, clinical presentation, diagnosis and management |
(Rus)
|
|
Yarikov A., Morev A., Shpagin М., Fryerman A.
|
| 卷 13, 编号 2 (2019) |
The haemorrhagic transformation of cerebral infarction: classification; pathogenesis; predictors and effect on the functional outcome |
(Rus)
|
|
Khasanova D., Kalinin M., Ibatullin М., Rakhimov I.
|
| 卷 13, 编号 1 (2019) |
Current view on phenotypic and genetic features of autosomal recessive inherited peripheral neuropathies |
(Rus)
|
|
Murtazina A., Shchagina O., Nikitin S., Dadali E., Polyakov A.
|
| 卷 12, 编号 5S (2018) |
Neurovascular coupling and cerebral perfusion in aging, cerebral microangiopathy and Alzheimer’s diseases |
(Rus)
|
|
Dobrynina L.
|
| 卷 12, 编号 5S (2018) |
Gender features in neurological disorders |
(Rus)
|
|
Bogolepova I.
|
| 卷 12, 编号 5S (2018) |
Monoclonal antibodies in neurology: current state and future development |
(Rus)
|
|
Zakharova M.
|
| 卷 12, 编号 5S (2018) |
Epilepsy and sleep |
(Rus)
|
|
Broutian A., Belyakova-Bodina A.
|
| 卷 12, 编号 5S (2018) |
Influence of genetic factors on neurophysiological mechanisms of neurodegenerative diseases |
(Rus)
|
|
Ponomareva N., Fokin V., Rogaev E., Illarioshkin S.
|
| 卷 12, 编号 5S (2018) |
Methods of immunohistochemistry and computerized morphometry as promising tools in the study of pathogenic patterns of neurodegenerative processes |
(Rus)
|
|
Khudoerkov R., Salkov V., Voronkov D.
|
| 卷 12, 编号 5S (2018) |
Current problems of synaptic plasticity |
(Rus)
|
|
Skrebitsky V., Sharonova I.
|
| 卷 12, 编号 5S (2018) |
Cellular models of the nervous system diseases |
(Rus)
|
|
Khaspekov L.
|
| 卷 12, 编号 5S (2018) |
Modeling of age-dependent disorders: relationship between the nervous and endocrine systems |
(Rus)
|
|
Stavrovskaya A., Voronkov D., Shestakova E., Ol’shansky A., Yamshchikova N., Gushchina A., Illarioshkin S.
|
| 卷 12, 编号 5S (2018) |
Structural and functional basis of chronic disorders of consciousness |
(Rus)
|
|
Piradov M., Suponeva N., Sergeev D., Chervyakov A., Ryabinkina Y., Sinitsyn D., Poydasheva A., Kremneva E., Morozova S., Yazeva E., Legostaeva L.
|
| 卷 12, 编号 5S (2018) |
Neurotransplantation: the time has come? |
(Rus)
|
|
Illarioshkin S.
|
| 卷 12, 编号 5S (2018) |
New horizons of non-invasive brain stimulation in clinical medicine |
(Rus)
|
|
Poydasheva A., Bakulin I., Suponeva N., Troshina E., Tanashyan M., Dedov I., Piradov M.
|
| 卷 12, 编号 5S (2018) |
Modern aspects of surgical neuromodulation |
(Rus)
|
|
Gushcha A., Tyurnikov V., Kashcheev A.
|
| 卷 12, 编号 5S (2018) |
Autonomic support of cognitive functions and functional asymmetry in normal aging and chronic cerebrovascular disorders |
(Rus)
|
|
Fokin V., Ponomareva N., Medvedev R., Shabalina A., Tanashyan M., Lagoda O.
|
| 卷 12, 编号 4 (2018) |
Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis |
(Rus)
|
|
Zakharova M., Lysogorskaia E., Ivanova M., Kochergin I., Korzhova Y.
|
| 卷 12, 编号 4 (2018) |
Pain syndrome in degenerative spine conditions |
(Rus)
|
|
Gushcha A., Gerasimova E., Poltorako Y.
|
| 卷 12, 编号 3 (2018) |
Surgical methods of treatment of back pain syndrome recurrence in the degenerative pathology of the lumbar spine |
(Rus)
|
|
Shnyakin P., Botov A., Amelchenko A.
|
| 卷 12, 编号 3 (2018) |
The role of personality disorders in the management of patients with pharmacoresistant epilepsy after neurosurgical resections |
(Rus)
|
|
Narodova E., Schneider N., Narodov A., Dmitrenko D., Strotskaya I., Moskaleva P.
|
| 卷 12, 编号 3 (2018) |
Theoretical basis for classical methods of motor rehabilitation in neurology |
(Rus)
|
|
Ustinova K., Chernikova L., Khizhnikova A., Poydasheva A., Suponeva N., Piradov M.
|
| 卷 12, 编号 2 (2018) |
Clinical heterogeneity of progressive supranuclear palsy |
(Rus)
|
|
Tappakhov A., Popova T., Govorova T., Petrova A.
|
| 卷 12, 编号 2 (2018) |
Experimental evaluation of bioequivalenceт of the original and generic peptide drugs in multiple sclerosis |
(Rus)
|
|
Ryabtseva M., Neugodova N., Batuashvili T., Simutenko L.
|
| 卷 12, 编号 1 (2018) |
MRI in the assessment of cerebral small vessel disease |
(Rus)
|
|
Gnedovskaya E., Dobrynina L., Krotenkova M., Sergeeva A.
|
| 卷 11, 编号 4 (2017) |
Non-motor symptoms of Parkinson’s disease: the submerged part of the iceberg |
(Rus)
|
|
Titova N., Chaudhuri К.
|
| 卷 11, 编号 4 (2017) |
Ischemic stroke and inherited thrombophilias |
(Rus)
|
|
Pizova N.
|
| 卷 11, 编号 3 (2017) |
Chemical angioplasty for the treatment of cerebral vasospasm in patients with ruptured cerebral aneurysm |
(Rus)
|
|
Kalinkin A., Petrikov S.
|
| 卷 11, 编号 3 (2017) |
Neuroanatomic differences of the brain in males and females |
(Rus)
|
|
Polunina A., Bryun E.
|
| 卷 11, 编号 2 (2017) |
Structural and functional neuroimaging in amyotrophic lateral sclerosis |
(Rus)
|
|
Bakulin I., Chervyakov A., Kremneva E., Konovalov R., Zakharova M.
|
| 卷 11, 编号 2 (2017) |
Monoclonal Antibodies: Present and Future in the Treatment of Multiple Sclerosis (Based on the Proceedings of the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ECTRIMS) |
(Rus)
|
|
Votintseva M., Petrov A., Stolyarov I.
|
| 卷 11, 编号 1 (2017) |
Small fiber neuropathy |
(Rus)
|
|
Suponeva N., Belova N., Zaitseva N., Yusupova D., Lagoda D., Korepina O., Piradov M.
|
| 卷 11, 编号 1 (2017) |
Prognostic factors for recovery of motor dysfunction following ischemic stroke |
(Rus)
|
|
Barkhatov Y., Kadykov A.
|
| 卷 7, 编号 1 (2013) |
Mechanisms of neuroplastisity and rehabilitation in hyperacute period of stroke |
(Rus)
|
|
Sidyakina I., Schapovalenko T., Lyadov K.
|
| 卷 9, 编号 1 (2015) |
Balo’s concentric sclerosis: is it pathogenic subtype of Multiple Sclerosis or distinct disorder? |
(Rus)
|
|
Vorobyeva A., Konovalov R., Krotenkova M., Peresedova A., Zakharova M.
|
| 卷 9, 编号 1 (2015) |
Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 1. Acute stroke |
(Rus)
|
|
Piradov M., Tanashyan M., Domashenko M., Sergeev D., Maksimova M.
|
| 卷 9, 编号 1 (2015) |
Mechanisms of therapeutic hypothermia effect on brain damage in hypoxia and ischemia |
(Rus)
|
|
Popugaev K., Hutorenko A.
|
| 卷 9, 编号 1 (2015) |
Distal diabetic neuropathy: review of evidence-based recommendations |
(Rus)
|
|
Beregovsky V., Khramilin V., Demidova I., Strokov I., Guryeva I.
|
| 卷 6, 编号 1 (2012) |
Creutzfeldt-Jakob disease: current issues (review) |
(Rus)
|
|
Peresedova A., Zavalishin I.
|
| 卷 6, 编号 2 (2012) |
Modern ethical aspects of clinical trials in patients with multiple sclerosis |
(Rus)
|
|
Ivashkova E., Petrov A., Votintseva M., Shkilnyuk G., Stolyarov I.
|
| 卷 6, 编号 2 (2012) |
Polyamines: their role in normal condition and in disorders of the central neural systems |
(Rus)
|
|
Berezov T., Makletsova M., Fedorova T.
|
| 卷 6, 编号 2 (2012) |
Myotonic dystrophy type 2 |
(Rus)
|
|
Rudenskaya G., Polyakov A.
|
| 卷 6, 编号 3 (2012) |
Episodic memory: neurological and neuromediator mechanisms |
(Rus)
|
|
Polunina A., Bryun E.
|
| 卷 7, 编号 1 (2013) |
About astroglia in the brain and pathology |
(Rus)
|
|
Goryaynov S., Protsky S., Okhotin V., Pavlova G., Revischin A., Potapov A.
|
| 卷 6, 编号 4 (2012) |
Blood-brain barrier models in vitro: current situation and prospects |
(Rus)
|
|
Morgun A., Kuvacheva N., Kоmleva Y., Pozhilenkova E., Kutishcheva I., Gagarina E., Taranushenko T., Ozerskaya A., Okuneva O., Salmina A.
|
| 卷 8, 编号 1 (2014) |
Statins and ischemic stroke prevention and treatment |
(Rus)
|
|
Fonyakin A., Geraskina L.
|
| 卷 8, 编号 4 (2014) |
Extrapyramidal movement disorders in patients after stroke |
(Rus)
|
|
Pizova N.
|
| 卷 8, 编号 4 (2014) |
Regenerative potential of the brain: composition and forming of regulatory microenvironment in neurogenic niches |
(Rus)
|
|
Komleva Y., Kuvacheva N., Malinovskaya N., Gorina Y., Lopatina O., Teplyashina E., Pozhilenkova E., Zamay A., Morgun A., Salmina A.
|
| 卷 8, 编号 4 (2014) |
Neurological complications in acute leukemia in children |
(Rus)
|
|
Shchugareva L., Iova A., Ivanova O., Boychenko E., Garbuzova I., Stancheva N., Bondarenko S., Khutornaya T., Zubarovskaya L.
|
| 卷 9, 编号 3 (2015) |
Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 2. Chronic cerebrovascular diseases. |
(Rus)
|
|
Piradov M., Tanashyan M., Domashenko M., Maksimova M.
|
| 卷 7, 编号 2 (2013) |
Genetics of hereditary forms of dystonia |
(Rus)
|
|
Krasnov M., Timerbaeva S., Illarioshkin S.
|
| 卷 7, 编号 4 (2013) |
General principles of neuron organization in the human dorsal thalamus nuclei |
(Rus)
|
|
Berezhnaya L.
|
| 卷 9, 编号 3 (2015) |
New capabilities of laboratory diagnosis of thromboses |
(Rus)
|
|
Shabalina A., Kostyreva M., Tanashyan M.
|
| 卷 7, 编号 4 (2013) |
Neurodegeneration with brain iron accumulation |
(Rus)
|
|
Rudenskaya G., Zakharova E.
|
| 卷 7, 编号 3 (2013) |
Vascular aspects of multiple sclerosis: myth or reality? |
(Rus)
|
|
Peresedova A., Kulikova S., Zavalishin I.
|
| 卷 9, 编号 3 (2015) |
Сerebrotendinous xanthomatosis |
(Rus)
|
|
Rudenskaya G., Zakharova E.
|
| 卷 9, 编号 2 (2015) |
Dystonic hyperkinesias in children of early childhood |
(Rus)
|
|
Bobylova M., Kakaulina V., Il’ina E., Nekrasova I., Pechatnikova N., Mikhaylova S., Mironov M., Mironov K.
|
| 卷 8, 编号 3 (2014) |
The value of various brain pathways impairment in the post-stroke rehabilitation of walking function |
(Rus)
|
|
Kadykov A., Barkhatov Y.
|
| 卷 8, 编号 3 (2014) |
Modern pharmacological models of Alzheimer’s disease |
(Rus)
|
|
Kolobov V., Storozheva Z.
|
| 卷 8, 编号 2 (2014) |
Myeloproliferative diseases and ischemic stroke |
(Rus)
|
|
Tanashyan M., Kuznetsova P., Lagoda O., Shabalina A., Subortseva I., Melikyan A.
|
| 卷 8, 编号 2 (2014) |
Reproductive health of women with multiple sclerosis |
(Rus)
|
|
Tikhonovskaya O., Pinchuk A., Alifirova V., Musina N.
|
| 卷 8, 编号 1 (2014) |
Features of in vitro, in silico and transgenic models of Alzheimer’s disease |
(Rus)
|
|
Kolobov V., Storozheva Z.
|
| 卷 8, 编号 2 (2014) |
D-amino acids in the pathogenesis of neurodegenerative diseases and in normal ageing |
(Rus)
|
|
Chervyakov A., Zakharova M., Pestov N.
|
| 卷 9, 编号 4 (2015) |
Modern tendencies in the development of the patch-clamp technique: new opportunities for neuropharmacology and neurobiology |
(Rus)
|
|
Shuvaev A., Salmin V., Kuvacheva N., Pozhilenkova E., Salmina А.
|
| 卷 9, 编号 4 (2015) |
A genome editing technology and capabilities of its application in cellular neurobiology |
(Rus)
|
|
Vetchinova А., Konovalova E., Lunev E., Illarioshkin S.
|
| 卷 9, 编号 4 (2015) |
Endogenous retrovirus: from fundamental studies to etiotropic therapy of multiple sclerosis |
(Rus)
|
|
Zakharova M., Logunov D., Kochergin I., Bakulin I.
|
| 卷 10, 编号 1 (2016) |
Aspirin resistance: clinical and molecular genetic evaluation techniques |
(Rus)
|
|
Tanashyan M., Domashenko M., Raskurazhev A.
|
| 卷 10, 编号 1 (2016) |
A clinical value of neuroplasticity in ischemic stroke |
(Rus)
|
|
Damulin I., Ekusheva E.
|
| 卷 10, 编号 1 (2016) |
A role of genetic factors in the development of individual predisposition to ischemic stroke |
(Rus)
|
|
Korchagin V., Mironov K., Dribnokhodova O., Maksimova M., Illarioshkin S., Tanashyan M., Platonov A., Shipulin G., Raskurazhev A., Piradov M.
|
| 卷 10, 编号 2 (2016) |
Adult-onset leukoencephalopathy with vanishing white matter |
(Rus)
|
|
Rudenskaya G., Zakharova E.
|
| 卷 10, 编号 2 (2016) |
DYT6 form of idiopathic dystonia |
(Rus)
|
|
Krasnov M., Timerbaeva S., Abramycheva N., Stepanova M., Shpilyukova Y., Ershova M.
|
| 卷 10, 编号 3 (2016) |
Posterior cortical atrophy as a variant of progressive local brain atrophy |
(Rus)
|
|
Belopasova A., Kadykov A., Berdnikovich E., Kashina E.
|
| 卷 10, 编号 4 (2016) |
The vascular type of Ehlers–Danlos syndrome |
(Rus)
|
|
Gubanova M., Dobrynina L., Kalashnikova L.
|
| 1 - 127 的 127 信息 |
|
